Abiraterone Acetate
Rank #53 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$345.0M
Total Cost
122,643
Total Claims
$345.0M
Total Cost
2,762
Prescribers
$2,813
Cost per Claim
11,252
Beneficiaries
127,371
30-Day Fills
$125K
Avg Cost/Provider
44
Avg Claims/Provider
Share of Medicare Part D Spending
0.13%
of total Medicare Part D spending
$345.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $345.0M total
🔎 Data Overview
At $2,813 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $124,903 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $30,660 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Abiraterone Acetate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Sukumar Ethirajan | Hematology | Overland Park, KS | 966 | $2.7M |
| 2 | Antony Ruggeri | Hematology-Oncology | Milwaukee, WI | 474 | $1.9M |
| 3 | Ki May Tung | Nurse Practitioner | Honolulu, HI | 322 | $1.8M |
| 4 | Dinara Abubakirova | Nurse Practitioner | New York, NY | 279 | $1.6M |
| 5 | Deaglan Mchugh | Medical Oncology | New York, NY | 347 | $1.5M |
| 6 | David Morris | Urology | Hendersonville, TN | 378 | $1.4M |
| 7 | Sundhar Ramalingam | Medical Oncology | Durham, NC | 344 | $1.4M |
| 8 | Eugenio Galindo | Hematology-Oncology | Mcallen, TX | 297 | $1.4M |
| 9 | John Henegan | Hematology-Oncology | Jackson, MS | 291 | $1.3M |
| 10 | John Shen | Hematology-Oncology | Los Angeles, CA | 297 | $1.3M |
| 11 | Jennifer Arnold | Physician Assistant | Williamsville, NY | 456 | $1.2M |
| 12 | Song Zhao | Medical Oncology | Seattle, WA | 554 | $1.2M |
| 13 | Tarenne Carrington | Nurse Practitioner | Philadelphia, PA | 288 | $1.2M |
| 14 | Arash Rezazadeh Kalebasty | Hematology-Oncology | Orange, CA | 236 | $1.2M |
| 15 | Victoria Sinibaldi | Nurse Practitioner | Baltimore, MD | 216 | $1.2M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 50 | Apalutamide (Erleada) | $369.2M | 24,956 |
| 51 | Secukinumab (Cosentyx Sensoready (2 Pens)) | $347.7M | 45,496 |
| 52 | Upadacitinib (Rinvoq) | $346.0M | 51,469 |
| 53 | Abiraterone Acetate (Abiraterone Acetate) | $345.0M | 122,643 |
| 54 | Icosapent Ethyl (Vascepa) | $334.9M | 692,252 |
| 55 | Cariprazine Hcl (Vraylar) | $329.1M | 226,854 |
| 56 | Albuterol Sulfate (Albuterol Sulfate Hfa) | $312.2M | 7,904,120 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology